Market Research Logo

Global HPV Vaccine Market: Analysis By End-User (Male, Female), By Age Group (Adolescents, Adults) - By Region, By Country (2017-2022) -– By Region (North America, Europe, APAC and RoW), By Country (US, Canada, UK, Germany, France, China, India, Japan)

Global HPV Vaccine Market: Analysis By End-User (Male, Female), By Age Group (Adolescents, Adults) - By Region, By Country (2017-2022) -– By Region (North America, Europe, APAC and RoW), By Country (US, Canada, UK, Germany, France, China, India, Japan)

Executive Summary

A comprehensive research report created through extensive primary research (inputs from industry experts, companies, stakeholders) and secondary research, the report aims to present the analysis of Global HPV Vaccine Market by End-User (Male and Female), By Age-Group (Adolescent and Adults), By Region (North America, Europe, Asia Pacific, Rest of the world) and By Country (U.S., Canada, United Kingdom, Germany, France, Japan China, India).

According to Azoth Analytics research report “Global HPV Vaccine Market: Analysis By End-User (Male, Female), By Age Group (Adolescents, Adults) - By Region, By Country (2017-2022) – By Region (North America, Europe, APAC and RoW), By Country (US, Canada, UK, Germany, France, China, India, Japan)”, the global market is projected to display a robust growth represented by a CAGR of 4.18% during 2017 – 2022.

The segment of Female HPV vaccine market witnessed growth at a noteworthy rate over the past few years and is expected to grow in the forecast period on the back of rising awareness regarding HPV related fatal diseases, rising healthcare expenditures along with rising disposable incomes. Amongst the regions, North America accounts for the largest regional share in the global HPV vaccine market in 2017. Key factors driving the robust growth rate of North America region include emergence of second generation of HPV vaccines with lower dosage schedule and increasing HPV vaccination recommendation for male adolescents and adult population, increasing number of patients diagnosed with anogenital and oropharynx cancers as well as rising prevalence of HPV virus.

The report titled “Global HPV Vaccine Market: Analysis By End-User (Male, Female), By Age Group (Adolescents, Adults) - By Region, By Country (2017-2022) – By Region (North America, Europe, APAC and RoW), By Country (US, Canada, UK, Germany, France, China, India, Japan)” has covered and analysed the potential of Global HPV Vaccine Market and provides statistics and information on market size, shares and growth factors. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment evaluation. Besides, the report also identifies and analyses the emerging trends along with major drivers, challenges and opportunities in the global HPV vaccine market. Additionally, the report also highlights market entry strategies for various companies across the globe.

Scope of the Report

Global HPV Vaccine Market (Actual Period: 2012-2016, Forecast Period: 2017-2022

  • Global HPV Vaccine Market – Size and Growth
  • By End User – Male and Female
  • By Age Group – Adolescent and Adults
Regional Markets – North America, Europe, Asia-Pacific and Rest of the World (Actual Period: 2012-2016, Forecast Period: 2017-2022)
  • HPV Vaccine Market – Size and Growth
  • By End User – Male and Female
  • By Age Group – Adolescent and Adults
Country Analysis - U.S., Canada, United Kingdom, Germany, France, Japan, China, India
  • HPV vaccine Market – Size and Growth
  • By End User – Male and Female
Other Report Highlights
  • Market Dynamics – Drivers and Restraints
  • Market Trends
  • Porter Five Force Analysis
  • Policy and Regulatory Landscape
  • Company Analysis – Merck and Co,, GlaxoSmithKline 


1. Research Methodology
2. Executive Summary
3. Strategic Recommendations
4. HPV Vaccine Market: Product Outlook
Table A: Globally approved HPV vaccines, 2016
Table B: HPV Vaccine Market Segmentation Flowchart
5. Global HPV Vaccine Market: Growth and Forecast
5.1. Global HPV Vaccine Market, By Value (2012-2016)
Table 1: Global HPV vaccine Market Size, By Value, 2012-2016 (USD Million)
Table 2: World Male Population Estimates, 2017 (In Millions)
Table 3: World Female Population Estimates, 2017 (In Millions)
Table 4: World Female Population, Age 10-14 Years Old (2012-2016)
Table 5: World Male Population, Age 10-14 Years Old (2012-2016)
Table 6: Global Healthcare Expenditure, 2012-2016 (In Trillion)
Table 7: Top 10 Most Frequent Cancer in Females, World, (Age-standardised incidence rate per 100,000 women)
Table 8: Top 10 Most Frequent Cancer Deaths in Females, World, (Age-standardised incidence rate per 100,000 women)
Table 9: Age-Standardized Cervical Cancer Incidence Rate (per 100,000 women per year), By Region
Table 10: HPV Related Cancer Cases in Women/ Year, 530,000
Table 11: HPV Related Cancer Cases in Men/ Year, 39,000
5.2. Global HPV Vaccine Market, By Value (2017-2022)
Table 12: Global HPV Vaccine Market Size, By Value, 2017-2022 (USD Million)
5.3. Global HPV Vaccine Market - By End-User, By Value
5.3.1. Global HPV Vaccine Market, By Value, % (2016)
Table 13: Global HPV vaccine Market Size, By End-User, 2016 (%)
5.3.2. Global HPV Vaccine Market, By Value, % (Forecast 2022F)
Table 14: Global HPV Vaccine Market Size, By End-User, 2022 (%)
5.4. Global HPV Vaccine Market, By End-User, By Value (2012-2022)
5.4.1. Male, By Value (2012-2022)
Table 15: Global HPV Vaccine Market - End-User, By Value 2012-2022 (USD Million)
5.4.2. Female, By Value (2012-2022)
Table 15: Global HPV Vaccine Market - End-User, By Value 2012-2022 (USD Million)
5.5. Global HPV Vaccine Market, By Age-Group, By Value (2012-2022)
5.5.1. Adolescent, By Value (2012-2022)
Table 16: Global HPV Vaccine Market – By Age Group, By Value 2012-2022 (USD Million)
5.5.2. Adult, By Value (2012-2022)
Table 16: Global HPV Vaccine Market – By Age Group, By Value 2012-2022 (USD Million)
6. North America HPV Vaccine Market: Growth and Forecast
6.1. North America HPV Vaccine Market, By Value (2012-2016)
Table 17: North America HPV Vaccine Market Size, By Value, 2012-2016 (USD Million)
Table 18: North America GDP, 2012-2015 (USD Trillion)
Table 19: North America GDP, By Select Country, 2016 (USD Trillion)
Table 20: North America Healthcare Cost Per Capita, By Select Country, 2016 (USD)
Table 21: North America Female Population, Age 10-14 Years Old (2012-2016)
Table 22: North America Male Population, Age 10-14 Years Old (2012-2016)
6.2. North America HPV Vaccine Market, By Value (2017-2022)
Table 23: North America HPV Vaccine Market Size, By Value, 2017-2022(USD Million)
6.3. North America HPV Vaccine Market - By End-User, By Value
6.3.1. North America HPV Vaccine Market, By Value, % (2016)
Table 24: North America HPV vaccine Market Size, By End-User, 2016 (%)
6.3.2. North America HPV Vaccine Market, By Value, % (Forecast 2022F)
Table 25: North America HPV Vaccine Market Size, By End-User, 2022 (%)
6.4. North America HPV Vaccine Market, By End-User, By Value (2012-2022)
6.4.1. Male, By Value (2012-2022)
Table 26: North America HPV Vaccine Market, End-User, By Value 2012-2022 (USD Million)
6.4.2. Female, By Value (2012-2022)
Table 26: North America HPV Vaccine Market, End-User, By Value 2012-2022 (USD Million)
6.5. North America HPV Vaccine Market, By Age-Group, By Value (2012-2022)
6.5.1. Adolescent, By Value (2012-2022)
Table 27: North America HPV Vaccine Market, By Age Group, By Value 2012-2022 (USD Million)
6.5.2. Adult, By Value (2012-2022)
Table 27: North America HPV Vaccine Market, By Age Group, By Value 2012-2022 (USD Million)
6.6. North America HPV Vaccine Market: Country Analysis (U.S., Canada)
6.6.1. North America HPV Vaccine Market, Country Share, 2016 (% of Total)
Table 28: North America HPV Vaccine Market, Country Share, 2016 (% of Total)
6.6.2. North America HPV Vaccine Market, Country Share, 2022 (% of Total)
Table 29: North America HPV Vaccine Market, Country Share, 2022 (% of Total)
6.7. U.S. HPV Vaccine Market: Growth and Forecast
6.7.1. U.S. HPV Vaccine Market, By Value (2012-2016)
Table 30: U.S. HPV Vaccine Market Size, By Value, 2012-2022 (USD Million)
6.7.2. U.S. HPV Vaccine Market, By Value (2017-2022)
Table 30: U.S. HPV Vaccine Market Size, By Value, 2012-2022 (USD Million)
Table C: Estimated number of HPV Associated cases in 2017
Table 31: U.S. Female Population, Age 10-14 Years Old (2012-2016)
Table 32: U.S. Male Population, Age 10-14 Years Old (2012-2016)
Table 33: U.S. Per Capita Healthcare Expenditure, 2012-2016 (In USD)
Table 34: U.S. HPV vaccine Market Size, By End-User, 2016 (%)
Table 35: U.S. HPV Vaccine Market Size, By End-User, 2022 (%)
6.8. U.S. HPV Vaccine Market - By End-User, By Value
6.8.1. Male, By Value (2012-2022)
Table 36: U.S. HPV Vaccine Market - End-User, By Value 2012-2022 (USD Million)
6.8.2. Female, By Value (2012-2022)
Table 36: U.S. HPV Vaccine Market - End-User, By Value 2012-2022 (USD Million)
Table 37: Annual Sales of Cervarix vaccines in U.S., (In Million USD) 2012-2016
6.9. Canada HPV Vaccine Market: Growth and Forecast
6.9.1. Canada HPV Vaccine Market, By Value (2012-2016)
Table 38: Canada HPV Vaccine Market Size, By Value, 2012-2022 (USD Million)
6.9.2. Canada HPV Vaccine Market, By Value (2017-2022)
Table 38: Canada HPV Vaccine Market Size, By Value, 2012-2022 (USD Million)
Table 39: Canada Female Population, Age 10-14 Years Old (2012-2016)
Table 40: Canada Male Population, Age 10-14 Years Old (2012-2016)
Table D: Estimated new HPV related cancers cases, 2011, 2012 & 2016
Table 41: Normal Cytology
Table 42: Low-Grade lesions
Table 43: High-Grade lesions
Table 44: Cervical Cancer
Table 45: Prevalence of Cervical Cancer among female (Patients per 100,000) (2012-2016)
Table 46: Canada HPV vaccine Market Size, By End-User, 2016 (%)
Table 47: Canada HPV Vaccine Market Size, By End-User, 2022 (%)
6.10. Canada HPV Vaccine Market - By End-User, By Value
6.10.1. Male, By Value (2012-2022)
Table 48: Canada HPV Vaccine Market - By End-User, By Value 2012-2022 (USD Million)
6.10.2. Female, By Value (2012-2022)
Table 48: Canada HPV Vaccine Market - By End-User, By Value 2012-2022 (USD Million)
7. Europe HPV Vaccine Market: Growth and Forecast
7.1. Europe HPV Vaccine Market, By Value (2012-2016)
Table 49: Europe HPV Vaccine Market Size, By Value, 2012-2016 (USD Million)
7.2. Europe HPV Vaccine Market, By Value (2017-2022)
Table 49: Europe HPV Vaccine Market Size, By Value, 2012-2016 (USD Million)
Table 50: Europe, Female Population aged 15+, By Region, 2017 (In Millions)
Table 51: European Union, Per Capita Healthcare Expenditure, 2012-2014 (In USD)
Table 52: Europe Female Population, Age 10-14 Years Old (2012-2016)
Table 53: Europe Male Population, Age 10-14 Years Old (2012-2016)
Table 54: Europe, GDP, By Select Country, 2016 (USD Billion)
Table 55: Europe Health Spending Per Capita, By Select Country, 2016 (USD)
Table 56: Europe HPV Vaccine Market Size, By Value, Forecast, 2017-2022 (USD Million)
7.3. Europe HPV Vaccine Market - By End-User, By Value
7.3.1. Europe HPV Vaccine Market, By Value, % (2016)
Table 57: Europe HPV Vaccine Market Size, By End-User, 2016 (%)
7.3.2. Europe HPV Vaccine Market, By Value, % (Forecast 2022F)
Table 58: Europe HPV Vaccine Market Size, By End-User, 2022 (%)
7.4. Europe HPV Vaccine Market, By End-User, By Value (2012-2022)
7.4.1. Male, By Value (2012-2022)
Table 59: Europe HPV Vaccine Market - End-User, By Value 2012-2022 (USD Million)
7.4.2. Female, By Value (2012-2022)
Table 59: Europe HPV Vaccine Market - End-User, By Value 2012-2022 (USD Million)
7.5. Europe HPV Vaccine Market, By Age-Group, By Value (2012-2022)
7.5.1. Adolescent, By Value (2012-2022)
Table 60: Europe HPV Vaccine Market – By Age Group, By Value 2012-2022 (USD Million)
7.5.2. Adult, By Value (2012-2022)
Table 60: Europe HPV Vaccine Market – By Age Group, By Value 2012-2022 (USD Million)
7.6. Europe HPV Vaccine Market: Country Analysis (U.K., Germany, France & Rest of Europe)
7.6.1. Europe HPV Vaccine Market, Country Share, 2016 (% of Total)
Table 61: Europe HPV Vaccine Market, Country Share, 2016 (% of Total)
7.6.2. Europe HPV Vaccine Market, Country Share, 2022 (% of Total)
Table 62: Europe HPV Vaccine Market, Country Share, 2022 (% of Total)
Table 63: Annual Sales of Cervarix vaccines in Europe, (In Million USD) 2012-2016
7.7. U.K. HPV Vaccine Market: Growth and Forecast
7.7.1. U.K. HPV Vaccine Market, By Value (2012-2016)
Table 64: U.K. HPV Vaccine Market Size, By Value, 2012-2022 (USD Million)
7.7.2. U.K. HPV Vaccine Market, By Value (2017-2022)
Table 64: U.K. HPV Vaccine Market Size, By Value, 2012-2022 (USD Million)
Table E: Newly registered diagnosed cases of HPV related cancer in England, 2016
Table 65: U.K. Female Population, Age 10-14 Years Old (2012-2016)
Table 66: U.K. Male Population, Age 10-14 Years Old (2012-2016)
Table 67: Prevalence of Cervical Cancer among female (Patients per 100,000) (2012-2016)
Table 68: U.K., Per Capita Healthcare Expenditure, 2012-2016 (In USD)
Table 69: U.K. HPV Vaccine Market Size, By End User, 2016 (%)
Table 70: U.K. HPV Vaccine Market Size, By End User, 2022 (%)
7.8. U.K. HPV Vaccine Market - By End-User, By Value
7.8.1. Male, By Value (2012-2022)
Table 71: U.K. HPV Vaccine Market - End-User, By Value 2012-2022 (USD Million)
7.8.2. Female, By Value (2012-2022)
Table 71: U.K. HPV Vaccine Market - End-User, By Value 2012-2022 (USD Million)
7.9. Germany HPV Vaccine Market: Growth and Forecast
7.9.1. Germany HPV Vaccine Market, By Value (2012-2016)
Table 72: Germany HPV Vaccine Market Size, By Value, 2012-2022 (USD Million)
7.9.2. Germany HPV Vaccine Market, By Value (2017-2022)
Table 72: Germany HPV Vaccine Market Size, By Value, 2012-2022 (USD Million)
Table 73: Germany Female Population, Age 10-14 Years Old (2012-2016)
Table 74: Germany Male Population, Age 10-14 Years Old (2012-2016)
Table 75: Germany Per Capita Healthcare Expenditure, 2012 - 2014 (In USD)
Table 76: Prevalence of Cervical Cancer among female (Patients per 100,000) (2012-2016)
Table F: Estimated and Predicted HPV related cancer among male and female, 2011, 2012 & 2016
Table G: Estimated and Predicted HPV related cancer among female, 2011, 2012 & 2016
Table 77: Germany HPV Vaccine Market Size, By End User, 2016 (%)
Table 78: Germany HPV Vaccine Market Size, By End User, 2022 (%)
7.10. Germany HPV Vaccine Market - By End-User, By Value
7.10.1. Male, By Value (2012-2022)
Table 79: Germany HPV Vaccine Market - By End-User, By Value 2012-2022 (USD Million)
7.10.2. Female, By Value (2012-2022)
Table 79: Germany HPV Vaccine Market - By End-User, By Value 2012-2022 (USD Million)
7.11. France HPV Vaccine Market: Growth and Forecast
7.11.1. France HPV Vaccine Market, By Value (2012-2016)
Table 80: France HPV Vaccine Market Size, By Value, 2012-2022 (USD Million)
7.11.2. France HPV Vaccine Market, By Value (2017-2022)
Table 80: France HPV Vaccine Market Size, By Value, 2012-2022 (USD Million)
Table 81: Prevalence of Cervical Cancer among female (Patients per 100,000) (2012-2016)
Table 82: France Female Population, Age 10-14 Years Old (2012-2016)
Table 83: France Male Population, Age 10-14 Years Old (2012-2016)
Table 84: France Per Capita Healthcare Expenditure, 2012-2014 (In USD)
Table 85: France HPV Vaccine Market Size, By End-User, 2016 (%)
Table 86: France HPV Vaccine Market Size, By End-User, 2022 (%)
7.12. France HPV Vaccine Market - By End-User, By Value
7.12.1. Male, By Value (2012-2022)
Table 87: France HPV Vaccine Market - By End-User, By Value 2012-2022 (USD Million)
7.12.2. Female, By Value (2012-2022)
Table 87: France HPV Vaccine Market - By End-User, By Value 2012-2022 (USD Million)
7.13. Rest of Europe HPV Vaccine Market: Growth and Forecast
7.13.1. Rest of Europe HPV Vaccine Market, By Value (2012-2016)
Table 88: Rest of Europe HPV Vaccine Market Size, By Value, 2012-2022 (USD Million)
7.13.2. Rest of Europe Vaccine Market, By Value (2017-2022)
Table 88: Rest of Europe HPV Vaccine Market Size, By Value, 2012-2022 (USD Million)
8. Asia-Pacific HPV Vaccine Market: Growth and Forecast
8.1. Asia-Pacific HPV Vaccine Market, By Value (2012-2016)
Table 89: Asia-Pacific HPV Vaccine Market Size, By Value, 2012-2016 (USD Million)
Table H: Key Statistics on HPV burden in Asia
Table 90: Asia Female Population, Age 10-14 Years Old (2012-2016)
Table 91: Asia Male Population, Age 10-14 Years Old (2012-2016)
Table 92: APAC, GDP, By Select Country, 2016 (USD Billion)
Table 93: APAC Health Expenditure Per Capita, Public and Private, By Select Country, 2016 (USD)
8.2. Asia-Pacific HPV Vaccine Market, By Value (2017-2022)
Table 94: Asia-Pacific HPV Vaccine Market Size, By Value, 2017-2022 (USD Million)
8.3. Asia-Pacific HPV Vaccine Market - By End-User, By Value
8.3.1. Asia-Pacific HPV Vaccine Market, By Value, % (2016)
Table 95: Asia-Pacific HPV Vaccine Market Size, By End-User, 2016 (%)
8.3.2. Asia-Pacific HPV Vaccine Market, By Value, % (Forecast 2022F)
Table 96: Asia-Pacific HPV Vaccine Market Size, By End-User, 2022 (%)
8.4. Asia-Pacific HPV Vaccine Market, By End-User, By Value (2012-2022)
8.4.1. Male, By Value (2012-2022)
Table 97: Asia-pacific HPV Vaccine - End-User, By Value 2012-2022 (USD Million)
8.4.2. Female, By Value (2012-2022)
Table 97: Asia-pacific HPV Vaccine - End-User, By Value 2012-2022 (USD Million)
8.5. Asia-Pacific HPV Vaccine Market, By Age-Group, By Value (2012-2022)
8.5.1. Adolescent, By Value (2012-2022)
Table 98: Asia-Pacific HPV Vaccine Market – Age Group, By Value 2012-2022 (USD Million)
8.5.2. Adult, By Value (2012-2022)
Table 98: Asia-Pacific HPV Vaccine Market – Age Group, By Value 2012-2022 (USD Million)
8.6. Asia-Pacific HPV Vaccine Market: Country Analysis (Japan, China, India)
8.6.1. Asia-Pacific HPV Vaccine Market, Country Share, 2016 (% of Total)
Table 99: Asia-Pacific HPV Vaccine Market, Country Share, 2016 (% of Total)
8.6.2. Asia-Pacific HPV Vaccine Market, Country Share, 2022 (% of Total)
Table 100: Asia-Pacific HPV Vaccine Market, Country Share, 2022 (% of Total)
8.7. Japan HPV Vaccine Market: Growth and Forecast
8.7.1. Japan HPV Vaccine Market, By Value (2012-2016)
Table 101: Japan HPV Vaccine Market Size, By Value, 2012-2022 (USD Million)
8.7.2. Japan HPV Vaccine Market, By Value (2017-2022)
Table 101: Japan HPV Vaccine Market Size, By Value, 2012-2022 (USD Million)
Table 102: Japan HPV Vaccine Market Size, By End-User, 2016 (%)
Table 103: Japan HPV Vaccine Market Size, By End-User, 2022 (%)
8.8. Japan HPV Vaccine Market - By End-User, By Value
8.8.1. Male, By Value (2012-2022)
Table 104: Japan HPV Vaccine - End-User, By Value 2012-2022 (USD Million)
8.8.2. Female, By Value (2012-2022)
Table 104: Japan HPV Vaccine - End-User, By Value 2012-2022 (USD Million)
8.9. China HPV Vaccine Market: Growth and Forecast
8.9.1. China HPV Vaccine Market, By Value (2012-2016)
Table 105: China HPV Vaccine Market Size, By Value, 2012-2022 (USD Million)
8.9.2. China HPV Vaccine Market, By Value (2017-2022)
Table 105: China HPV Vaccine Market Size, By Value, 2012-2022 (USD Million)
Table 106: Prevalence of Cervical Cancer among female (Patients per 100,000) (2012-2016)
Table I: Estimated HPV related New Cancer Cases and Deaths (Thousands), By Sex, 2015
Table 107: China Female Population, Age 10-14 Years Old (2012-2016)
Table 108: China Male Population, Age 10-14 Years Old (2012-2016)
Table 109: China Per Capita Healthcare Expenditure, 2012-2014 (In USD)
Table 110: China HPV Vaccine Market Size, By End-User, 2016 (%)
Table 111: China HPV Vaccine Market Size, By End-User, 2022 (%)
8.10. China HPV Vaccine Market - By End-User, By Value
8.10.1. Male, By Value (2012-2022)
Table 112: China HPV Vaccine - By End-User, By Value 2012-2022 (USD Million)
8.10.2. Female, By Value (2012-2022)
Table 112: China HPV Vaccine - By End-User, By Value 2012-2022 (USD Million)
8.11. India HPV Vaccine Market: Growth and Forecast
8.11.1. India HPV Vaccine Market, By Value (2012-2016)
Table 113: India HPV Vaccine Market Size, By Value, 2012-2022 (USD Million)
8.11.2. India HPV Vaccine Market, By Value (2017-2022)
Table 113: India HPV Vaccine Market Size, By Value, 2012-2022 (USD Million)
Table 114: India Female Population, Age 10-14 Years Old (2012-2016)
Table 115: India Male Population, Age 10-14 Years Old (2012-2016)
Table 116: Prevalence of Cervical Cancer among female (Patients per 100,000) (2012-2016)
Table 117: India HPV Vaccine Market Size, By End-User, 2016 (%)
Table 118: India HPV Vaccine Market Size, By End-User, 2022 (%)
8.12. India HPV Vaccine Market - By End-User, By Value
8.12.1. Male, By Value (2012-2022)
Table 119: India HPV Vaccine - By End-User, By Value 2012-2022 (USD Million)
8.12.2. Female, By Value (2012-2022)
Table 119: India HPV Vaccine - By End-User, By Value 2012-2022 (USD Million)
Table 120: Rest of Asia-Pacific HPV Vaccine Market Size, By Value, 2012-2022 (USD Million)
9. ROW HPV Vaccine Market: Growth and Forecast
9.1. ROW HPV Vaccine Market, By Value (2012-2016)
Table 121: ROW HPV Vaccine Market Size, By Value, 2012-2016 (USD Million)
9.2. ROW HPV Vaccine Market, By Value (2017-2022)
Table 122: ROW HPV Vaccine Market Size, By Value, 2017-2022 (USD Million)
Table 123: Africa Female Population, Age 10-14 Years Old (2012-2016)
Table 124: Africa Male Population, Age 10-14 Years Old (2012-2016)
Table 125: Prevalence of Cervical Cancer, among women in Africa (Patients per 100,000 (2012-2016)
Table 126: Prevalence of Cervical Cancer among female in Brazil (Patients per 100,000 (2012-2016)
10. Market Dynamics
10.1. Increasing healthcare awareness about Sexually Transmissible Disease
10.2. Development of Healthcare Infrastructure
10.3. Rising global healthcare expenditure and favorable reimbursed policies
Table 127: Global Healthcare Expenditure, 2012-2016 (In Trillion)
11. Market Restraints
12. Market Trends
13. SWOT Analysis – HPV Vaccine Market
14. Porter’s Five Forces Analysis
15. Policy and Regulatory Landscape
Table 128: Annual Sales of HPV vaccines, By leading players, (In Million USD) 2012-2016
Table 129: Market Share of Leading players in HPV vaccine market, 2016
16. Company Profiles
16.1. Merck and Co
Table 130: Merck & Co., Net Sales, 2012-2016 (In million USD)
Table 131: Merck & Co, Net Sales of Gardasil/Gardasil 9, 2012-2016 (In million USD)
Table 132: Merck & Co., Net Sales, By Geographic Location, % Share 2016
Table 133: Merck & Co., Net Revenue, By Business Segment, % Share 2016
16.2. GlaxoSmithKline
Table 134: GlaxoSmithKline Annual Revenue, 2014-2016 (USD Million)
Table 135: Sales from Hepatitis Vaccination, GlaxoSmithKline, 2015 - 2016 (USD Million)
Table 136: GlaxoSmithKline Sales, By Region, 2016 (%)
Table 137: GlaxoSmithKline, Sales, By Segment 2016 (%)

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report